Glioblastoma is the most common malignant primary brain tumor in adults and is invariably fatal. Glioblastoma stem-like cells (GSCs) represent a dynamic subpopulation of glioblastoma cells, which are now known to exhibit treatment resistance and cause tumor recurrence. Therefore, knowledge of the mechanisms governing the GSC state is essential to develop effective therapies against glioblastoma. Using patient-derived glioblastoma cell lines, we have recently uncovered a requirement for the E3 ligase CDC20-Anaphase- Promoting Complex (CDC20-APC) in key GSC functions of invasion, self-renewal, and tumor initiation. Furthermore, we have identified the pluripotency regulatory transcription factor SOX2 as a novel CDC20- interacting protein, which mediates the downstream effects of CDC20-APC in GSCs in vitro. How exactly the CDC20-APC/SOX2 signaling pathway is regulated in GSCs and what role the CDC20-APC/SOX2 pathway plays in glioblastoma in vivo remain to be defined. The goals of our proposal are: 1) to identify the molecular mechanisms underlying the CDC20-APC/SOX2 pathway in GSC invasiveness, 2) to determine the impact of the CDC20-APC/SOX2 pathway on tumor initiation and maintenance in glioblastoma in vivo, and 3) to determine the effect of the CDC20-APC/SOX2 pathway on GSC responsiveness to standard-of-care chemotherapy temozolomide and radiation therapy. The long-term goal of this project is to develop novel CDC20-APC-directed therapeutic strategies to disrupt the GSC state and enhance the effectiveness of current treatments.

Public Health Relevance

The brain cancer glioblastoma remains a devastating disease despite multidisciplinary treatments, with a median survival of only 15 months. To development novel therapies for this lethal disease, our goal is to identify the molecular pathways that control a clinically important subpopulation of cancer cells called glioblastoma stem-like cells, which are resistant to conventional therapies and cause cancer recurrence. Here we propose to examine the role and detailed mechanisms of a protein complex called CDC20-Anaphase- Promoting Complex in the governance of glioblastoma stem-like cell properties, with the long-term goal of harnessing CDC20-APC-directed strategies to combat glioblastoma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS094670-02
Application #
9304357
Study Section
Clinical Neuroimmunology and Brain Tumors Study Section (CNBT)
Program Officer
Fountain, Jane W
Project Start
2016-07-01
Project End
2021-04-30
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Washington University
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Taiwo, Rukayat; Mahlokozera, Tatenda; Kim, Albert H (2018) Stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool. Stem Cell Investig 5:22
Gujar, Amit D; Mao, Diane D; Finlay, John B et al. (2018) Establishing Primary Human Glioblastoma Adherent Cultures from Operative Specimens. Methods Mol Biol 1741:53-62
Pan, Yanchun; Zhu, Ying; Yang, Wei et al. (2018) The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity. J Biol Chem 293:11850-11866
Gujar, Amit D; Le, Son; Mao, Diane D et al. (2016) An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc Natl Acad Sci U S A 113:E8247-E8256